Federal Register / Vol. 77, No. 99 / Tuesday, May 22, 2012 / Notices 30293 

Time and Date: 11:00 a.m.–5:30 p.m., June 

25, 2012 (Closed). 

Place: Teleconference. 

Status: The meeting will be closed to the 

public in accordance with provisions set 

forth in Section 552b(c)(4) and (6), Title 5 

U.S.C., and the Determination of the Director, 

Management Analysis and Services Office, 

CDC, pursuant to Public Law 92–463. 

Matters To Be Discussed: The meeting will 

include the initial review, discussion, and 

evaluation of ‘‘Identifying Barriers to 

Receiving Breast and Cervical Cancer 

Screening Among Muslim Women Living in 

the United Sates, SIP12–052, Panel B, initial 

review.’’ 

Contact Person for More Information: M. 

Chris Langub, Ph.D., Scientific Review 

Officer, CDC, 4770 Buford Highway NE., 

Mailstop F–46, Atlanta, Georgia 30341, 

Telephone: (770) 488–3585, EEO6@cdc.gov. 

The Director, Management Analysis and 

Services Office, has been delegated the 

authority to sign Federal Register notices 

pertaining to announcements of meetings and 

other committee management activities, for 

both the Centers for Disease Control and 

Prevention and the Agency for Toxic 

Substances and Disease Registry. 

Dated: May 15, 2012. 

Elaine L. Baker, 

Director, Management Analysis and Services 

Office, Centers for Disease Control and 

Prevention. 

[FR Doc. 2012–12352 Filed 5–21–12; 8:45 am] 

BILLING CODE 4163–18–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Disease Control and 

Prevention 

[Docket No. CDC–2012–0005] 

Recommendations for the 

Identification of Hepatitis C Virus 

(HCV) Chronic Infection 

AGENCY: Centers for Disease Control and 

Prevention (CDC), Department of Health 

and Human Services (HHS). 

ACTION: Notice with comment period. 

SUMMARY: The Centers for Disease 

Control and Prevention (CDC), located 

within the Department of Health and 

Human Services (HHS) announces draft 

recommendations for identification of 

persons with HCV chronic infection, 

available for public comment. The 

recommendations are intended to 

increase the proportion of persons with 

chronic HCV who are diagnosed, 

provided appropriate prevention 

services, and linked to needed care and 

treatment. Public comment will be used 

to inform the final recommendations. 

The Recommendations may be found at 

http://www.regulations.gov, Docket No. 

CDC–2012–0005. 

DATES: Written comments must be 

received on or before June 8th, 2012. 

ADDRESSES: You may submit comments, 

identified by Docket No. CDC–2012– 

0005, by any of the following methods: 

• Internet: Access the Federal 

eRulemaking portal at http:// 

www.regulations.gov. Follow the 

instructions for submitting comments. 

• Mail: Division of Viral Hepatitis, 

National Center for HIV/AIDS, Viral 

Hepatitis, STD, and TB Prevention, 

Centers for Disease Control and 

Prevention, 1600 Clifton Road, NE., 

Mailstop G–37, Atlanta, Georgia 30333. 

Instructions: All submissions received 

must include the agency name and 

docket number for this notice. All 

relevant comments will be posted 

without change to http:// 

www.regulations.gov including any 

personal information provided. 

Docket: For access to the docket to 

read background documents or 

comments received, go to http:// 

www.regulations.gov, Docket No. CDC– 

2012–0005. 

FOR FURTHER INFORMATION CONTACT: 

Rebecca Morgan, Division of Viral 

Hepatitis, National Center for HIV/ 

AIDS, Viral Hepatitis, STD, and TB 

Prevention, Centers for Disease Control 

and Prevention, 1600 Clifton Road, 

Mailstop G–37, Atlanta, Georgia 30333. 

You may also call 404–718–8596 or 

send an email to HCV_BC@cdc.gov. 

SUPPLEMENTARY INFORMATION: 

Hepatitis C virus infection is a 

contagious liver disease that ranges in 

severity from a mild illness lasting a few 

weeks to a serious, lifelong illness. It 

results from infection with the hepatitis 

C virus (HCV), which is spread 

primarily through contact with the 

blood of an infected individual. In 

approximately 75%–85% of persons, 

HCV persists as a chronic infection, 

which places infected persons at risk for 

liver cirrhosis, liver cancer or 

hepatocellular carcinoma (HCC), and 

complications involving other organ 

systems that develop over the decades 

following onset of infection. HCV 

infection status is determined by a 

blood test. 

In the United States an estimated 2.7– 

3.9 million persons are living with HCV 

infection. Cirrhosis, HCC and HCVrelated mortality have been increasing 

among persons infected with HCV, and 

these outcomes are projected to increase 

significantly in the coming decades. 

HCV-infected persons who are aware of 

their infection can benefit from health 

services to prevent additional harm to 

the liver (e.g., hepatitis A virus and 

hepatitis B virus vaccination), medical 

monitoring, and behavioral changes 

(e.g., reductions in alcohol use). Further, 

anti-viral therapies can clear HCV from 

the system (i.e., a virologic cure) and 

halt disease progression for many 

patients living with HCV infection. 

CDC is seeking public comment on 

these Recommendations, particularly 

concerning the following questions: 

(1) Are there other data, evidence, or 

studies to consider regarding: 

a. The burden of HCV infection 

morbidity, and mortality in the 

populations for whom testing is 

recommended? 

b. The number of persons living with 

HCV who are unaware of their infection 

status? 

c. The benefits and harms of HCV 

testing, care and treatment? 

d. The cost effectiveness of the 

proposed recommendations? 

e. Settings in a community where 

testing should be targeted? 

(2) Are there other factors, e.g., other 

scientific studies not referenced, which 

should be considered in the 

development of the Recommendations? 

(3) Are there any other comments 

about the utility of the information? 

Dated: May 15, 2012. 

Tanja Popovic, 

Deputy Associate Director for Science, 

Centers for Disease Control and Prevention. 

[FR Doc. 2012–12323 Filed 5–18–12; 11:15 am] 

BILLING CODE 4163–18–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Administration for Children and 

Families 

Submission for OMB Review; 

Comment Request 

Title: Child Care and Development 

Fund Annual Aggregate Report—ACF– 

800. 

OMB No.: 0970–0150. 

Description: Section 658K of the Child 

Care and Development Block Grant Act 

of 1990 (P.L. 101–508, 42 U.S.C. 9858) 

requires that States and Territories 

submit annual aggregate data on the 

children and families receiving direct 

services under the Child Care and 

Development Fund. The implementing 

regulations for the statutorily required 

reporting are at 45 CFR 98.70. Annual 

aggregate reports include data elements 

represented in the ACF–800 reflecting 

the scope, type, and methods of child 

care delivery. This provides ACF with 

the information necessary to make 

reports to Congress, address national 

child care needs, offer technical 

assistance to grantees, meet performance 

measures, and conduct research. 


srobinson on DSK4SPTVN1PROD with NOTICES